CPC A61K 31/513 (2013.01) [A61K 31/4418 (2013.01); A61K 31/4436 (2013.01); A61K 31/5377 (2013.01); A61P 1/16 (2018.01); C07D 213/70 (2013.01); C07D 239/56 (2013.01); C07D 409/04 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01)] | 12 Claims |
1. A compound represented by Formula (II):
![]() or a pharmaceutically acceptable salt or tautomer thereof, wherein:
X is O or ORh;
W is N;
L is —SCH2—;
R1 is absent, C6-C10 arylene or heteroarylene, wherein the heteroarylene comprises one or two 5- to 7-membered rings and 1-4 heteroatoms selected from N, O, and S, and wherein the C6-C10 arylene and heteroarylene are unsubstituted or substituted with one to two Re;
each R6 is independently at each occurrence H or C1-C4 alkyl;
R7 is A;
A is —(C(R6)2)rtetrazole;
Rc is H, halogen, or —CN;
Rd is —CF3, —CRfF2, —(C(R6)2)t—C6-C10 aryl, —(C(R6)2)t-5- or 6-membered heteroaryl;
each Re is independently at each occurrence C1-C6 alkyl, halogen, C1-C6 haloalkyl, —NHRz, —OH, or —CN;
Rf is H;
Rh is H;
Rj is absent;
Rz is H, C1-C6 alkyl, or C1-C6 haloalkyl;
each r is independently 0, 1, or 2;
each t is independently 1 or 2; and
![]() |